Key findings
- Preliminary: of 744 adults selected, 735 (98.8%) consented.
- Preliminary: 531 of 735 (72.2%) said they knew how mpox is transmitted; 201 (27.3%) did not.
- Preliminary: 138 of 735 (18.8%) reported mpox vaccination.
- Preliminary: 2 of 735 (0.3%) reported an mpox diagnosis by a health worker.
- Preliminary: 252 of 729 adults measured (34.6%) had blood pressure of 140/90 mmHg or higher.
About this study
Background
Sierra Leone reported 4,876 confirmed mpox cases and 42 deaths between 1 January and 20 July 2025, its largest mpox epidemic on record. The survey was run by the HEAL-SL team at Njala University.
Design
The survey aimed to reach about 800 adults in eight primary sampling units, four urban and four rural, chosen with the district health management teams. One of its five objectives is to estimate the seroprevalence of Orthopoxvirus-specific IgG from dried blood spots.
What was done
Fieldwork took place in September 2025. Teams enumerated 602 households with 1,554 residents, of whom 1,014 were eligible adults. Up to two adults per household were selected at random: 744 were selected and 735 (98.8%) consented. Each answered an electronic questionnaire, had blood pressure and blood glucose measured, and gave a finger-prick dried blood spot.
Results
Preliminary findings (23 October 2025), before laboratory analysis: 531 of 735 (72.2%) said they knew how mpox is transmitted, 138 (18.8%) reported mpox vaccination and 2 (0.3%) reported an mpox diagnosis. Of 729 with a blood pressure reading, 252 (34.6%) had 140/90 mmHg or higher.
Status
Laboratory analysis of the dried blood spots, feedback to the communities and a full report are the next steps. Laboratory results are not yet available.
Study team
- Partners
- Njala University
- National Public Health Agency of Sierra Leone